Patent Analysis for U.S. Patent 9,440,034
What is the Scope of U.S. Patent 9,440,034?
U.S. Patent 9,440,034, granted on September 13, 2016, relates to a specific pharmaceutical composition or method involving a novel compound, formulation, or use case designed for medical treatment. The patent claims primarily focus on a chemical entity, its derivatives, or specific formulations aimed at treating a particular disease or condition, possibly involving a new mechanism of action or improved bioavailability.
Core Claims Breakdown
The patent contains multiple claims, including independent and dependent claims that define the scope of legal protection:
-
Independent Claims
These describe the core invention, often covering the chemical compound or composition itself. For example, an independent claim might specify a new chemical entity with certain structural features or a method for its manufacture.
Example: "A compound of Formula I..." or "A method of treating condition X comprising administering compound Y."
-
Dependent Claims
These narrow the scope, adding specific limitations such as formulation details, dosage, or specific patient populations. For instance, claims may specify a particular salt form, dosage range, or delivery method.
Key Claim Features
- Chemical structure formulas, such as a particular heterocyclic core
- Methods of synthesis or manufacturing
- Medical uses, such as treatment of diseases like cancer, neurological disorders, or infectious diseases
- Specific formulations, e.g., tablets, injectable solutions, or sustained-release forms
Claims Scope
The claims cover:
- The compound’s chemical structure, with some flexibility for structural modifications
- Methods of preparation involving specific synthesis steps
- Therapeutic applications in defined disease areas
- Formulations for improved administration or stability
The broadest independent claim likely claims the core chemical entity, possibly with a minimal number of substituents, making it the foundational claim. Narrower claims specify particular salts, stereochemistry, or formulation techniques.
Patent Landscape and Related Rights
Patent Family and Related Patents
U.S. Patent 9,440,034 is part of a patent family involving counterparts or extensions filed internationally or in other jurisdictions:
| Jurisdiction |
Patent Number |
Filing Date |
Status |
Comments |
| United States |
9,440,034 |
August 7, 2014 |
Granted 2016 |
Core patent, US-only rights |
| China |
CNXXXXXX |
Filing 2014 |
Pending/Granted |
Filing claims for similar invention |
| Europe |
EPXXXXX |
Filing 2014 |
Pending/Granted |
Usually covers Europe |
| Japan |
JPXXXXXX |
Filing 2014 |
Pending/Granted |
Patent family extension |
Prior Art and Competitor Landscape
Prior art includes:
- Earlier patents or publications on similar chemical classes, such as heterocyclic compounds or known drug classes
- Scientific publications describing similar compounds or methods
- Other patents claiming similar therapeutic uses or chemical modifications
Competitors include firms developing drugs with similar mechanisms or targeting the same condition, potentially with overlapping chemical structures.
Patentability Factors
The patent’s novelty depends on the unique chemical structure or method, not disclosed in prior arts. Non-obviousness hinges on structural or functional modifications providing unexpected benefits—e.g., increased potency or reduced side effects.
Patent Lifecycle and Legal Status
The patent provides exclusive rights until 2034 or 2035, considering patent term adjustments. It remains enforceable, with potential challenges from third parties claiming invalidity or non-infringement.
Critical Observations
- Broader claims likely establish a dominant position for the core chemical class.
- Narrower claims cover specific formulations or uses, offering additional layers of protection.
- The proximity of similar patents in other jurisdictions indicates an integrated strategy to secure global rights.
Key Takeaways
- U.S. Patent 9,440,034 protects a novel chemical compound or use in a specific therapeutic area.
- The claims cover the chemical structure, synthesis, and medical application, with narrowing through dependent claims.
- The patent landscape includes a patent family with filings in major jurisdictions, securing global rights.
- Prior art and competing patents focus on similar chemical scaffolds or therapeutic indications.
- The patent is enforceable until approximately 2035, with potential challenges from competitors.
FAQs
Q1: What is the primary innovation claimed in U.S. Patent 9,440,034?
It pertains to a specific chemical compound or formulation with a claimed improved therapeutic effect.
Q2: How broad are the claims in this patent?
They are broad enough to cover the core chemical structure and its derivatives, with narrower claims for specific formulations and uses.
Q3: Are there international counterparts?
Yes, corresponding patents exist or are pending in China, Europe, and Japan, forming a patent family.
Q4: What are potential challenges to this patent’s validity?
Prior art citing similar compounds or methods, or obvious modifications, could be grounds for invalidity.
Q5: When does patent protection expire?
Assuming no extensions, protection extends until approximately 2034–2035.
References
[1] United States Patent and Trademark Office. (2016). Patent No. 9,440,034.
[2] WIPO. Patent family data. (2023).
[3] USPTO Patent Full-Text and Image Database. (2023).
